As filed with the Securities and Exchange Commission on December 21, 2020
Registration No. 333-188368
Registration No. 333-106007
Registration No. 333-104828
Registration No. 333-96541
Registration No. 333-87736
Registration No. 333-67370
Registration No. 333-59380
Registration No. 333-39238
Registration No. 333-94367
Registration No. 333-86611
Registration No. 333-40681
Registration No. 333-38055
Registration No. 333-26979
Registration No. 333-00391
Registration No. 033-59009
Registration No. 033-57583
Registration No. 33-52252
Registration No. 33-40295
Registration No. 33-40294
Registration No. 33-32875
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-8 REGISTRATION STATEMENT NO.
333-188368
POST-EFFECTIVE AMENDMENT NO. 1 TO FORM
S-8 REGISTRATION STATEMENT NO. 333-106007
POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-8 REGISTRATION STATEMENT NO.
333-104828
POST-EFFECTIVE AMENDMENT NO. 1 TO FORM
S-8 REGISTRATION STATEMENT NO. 333-96541
POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-8 REGISTRATION STATEMENT NO.
333-87736
POST-EFFECTIVE AMENDMENT NO. 2 TO FORM S-8
REGISTRATION STATEMENT NO. 333-67370
POST-EFFECTIVE AMENDMENT NO. 2 TO FORM S-8 REGISTRATION STATEMENT NO. 333-59380
POST-EFFECTIVE
AMENDMENT NO. 1 TO FORM S-8 REGISTRATION STATEMENT NO. 333-39238
POST-EFFECTIVE AMENDMENT NO. 2 TO FORM S-8 REGISTRATION STATEMENT NO.
333-93467
POST-EFFECTIVE AMENDMENT NO. 3 TO FORM S-8
REGISTRATION STATEMENT NO. 333-86611
POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-8 REGISTRATION STATEMENT NO. 333-40681
POST-EFFECTIVE
AMENDMENT NO. I TO FORM S-8 REGISTRATION STATEMENT NO. 333-38055
POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-8 REGISTRATION STATEMENT NO.
333-26979
POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-8
REGISTRATION STATEMENT NO. 333-00391
POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-8 REGISTRATION STATEMENT NO. 033-59009
POST-EFFECTIVE
AMENDMENT NO. 1 TO FORM S-8 REGISTRATION STATEMENT NO. 033-57583
POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-8 REGISTRATION STATEMENT NO.
33-52252
POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-8
REGISTRATION STATEMENT NO. 33-40295
POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-8 REGISTRATION STATEMENT NO. 33-40294
POST-EFFECTIVE
AMENDMENT NO. 1 TO FORM S-8 REGISTRATION STATEMENT NO. 33-32875
UNDER THE SECURITIES ACT OF 1933
JOHNSON & JOHNSON
(Exact name of registrant as specified in its charter)
|
|
|
New Jersey
|
|
22-1024240
|
(State or other jurisdiction of
incorporation or organization)
|
|
(I.R.S. Employer
Identification No.)
|
One Johnson & Johnson Plaza
New Brunswick, New Jersey 08933
(732) 524-0400
(Address of Principal Executive Offices)
JOHNSON & JOHNSON RETIREMENT SAVINGS PLAN
JOHNSON & JOHNSON SAVINGS PLAN FOR UNION REPRESENTED EMPLOYEES
JOHNSON & JOHNSON SAVINGS PLAN
JOHNSON & JOHNSON 2000 STOCK OPTION PLAN
SCIOS INC. 1992 EQUITY INCENTIVE PLAN
SCIOS INC. 1996 NON-OFFICER STOCK OPTION PLAN
JOHNSON & JOHNSON SAVINGS PLAN
ALZA CORPORATION TAX DEFERRAL INVESTMENT PLAN
SELFCARE, INC. EMPLOYEE STOCK PURCHASE PLAN
SELFCARE, INC. 1992 STOCK PLAN
SELFCARE, INC. 1994 INCENTIVE AND NONQUALIFIED STOCK OPTION PLAN
SELFCARE, INC. AMENDED AND RESTATED 1996 STOCK OPTION AND GRANT PLAN
STOCK OPTION GRANTS TO KEITH MAY, JEROME MCALEER AND DAVID SCOTT
INVERNESS MEDICAL TECHNOLOGY, INC. AMENDED AND RESTATED 2000 STOCK OPTION AND
GRANT PLAN INTEG INCORPORATED (FORMERLY INOMET, INC.) 1990 INCENTIVE AND STOCK
OPTION PLAN INTEG INCORPORATED (FORMERLY INOMET, INC.) 1991 INCENTIVE AND STOCK
OPTION PLAN INTEG INCORPORATED 1994 LONG-TERM INCENTIVE AND STOCK OPTION PLAN
INTEG INCORPORATED 1996 DIRECTORS STOCK OPTION PLAN
ALZA CORPORATION AMENDED AND RESTATED STOCK PLAN
ALZA CORPORATION AMENDED AND RESTATED EMPLOYEE STOCK PURCHASE PLAN
ALZA CORPORATION SUPPLEMENTAL EMPLOYEE STOCK PURCHASE PLAN
ALZA CORPORATION NONSTATUTORY STOCK OPTION PLAN
SEQUUS PHARMACEUTICALS, INC. 1987 EMPLOYEE STOCK OPTION PLAN
SEQUUS PHARMACEUTICALS, INC. 1987 CONSULTANT STOCK OPTION PLAN
SEQUUS PHARMACEUTICALS, INC. 1990 DIRECTOR STOCK PLAN
SEQUUS PHARMACEUTICALS, INC. EQUITY INCENTIVE PLAN
INNOVASIVE DEVICES, INC. 1992 STOCK OPTION PLAN
INNOVASIVE DEVICES, INC. 1996 NON-EMPLOYEE DIRECTOR STOCK PLAN
INNOVASIVE DEVICES, INC. 1996 OMNIBUS STOCK PLAN
CENTOCOR, INC. CONSULTANT NON-QUALIFIED STOCK OPTION AGREEMENTS
CENTOCOR, INC. 1983 INCENTIVE STOCK OPTION PLAN
CENTOCOR, INC. 1987 NON-QUALIFIED STOCK OPTION PLAN
CENTOCOR, INC. 1989 NON-EMPLOYEE DIRECTORS
NON-QUALIFIED STOCK OPTION PLAN
GYNECARE, INC., 1994 STOCK PLAN
GYNECARE, INC. 1995 DIRECTOR OPTION PLAN
JOHNSON & JOHNSON/BIOSENSE (ISRAEL) LTD. 1995 STOCK OPTION PLAN
JOHNSON &JOHNSON/BIOSENSE, INC. 1996 STOCK OPTION PLAN
JOHNSON & JOHNSON STOCK OPTION PLAN FOR NON-EMPLOYEE DIRECTORS
THE CORDIS CORPORATION NON-QUALIFIED STOCK OPTION PLAN
THE CORDIS CORPORATION DIRECTOR NON-QUALIFIED STOCK OPTION PLAN
THE WEBSTER LABORATORIES, INC. 1992 STOCK PLAN
JOHNSON & JOHNSON 1995 STOCK OPTION PLAN
JOHNSON & JOHNSON 1991 STOCK OPTION PLAN
MITEK SURGICAL PRODUCTS, INC. 1988 STOCK OPTION PLAN
MITEK SURGICAL PRODUCTS, INC. NON-EMPLOYEE DIRECTOR STOCK OPTION PLAN
JOHNSON & JOHNSON 1991 STOCK OPTION PLAN
(Full title of the plan)
Matthew
Orlando
Johnson & Johnson
Corporate Secretary
One
Johnson & Johnson Plaza
New Brunswick, New Jersey 08933
(Name and address of agent for service)
Telephone: (732) 524-0400
(Telephone number, including area code, of agent for service)
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a
non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of large accelerated filer, accelerated filer, smaller reporting
company and emerging growth company in Rule 12b-2 of the Securities Exchange Act of 1934.
|
|
|
|
|
|
|
Large accelerated filer
|
|
☒
|
|
Accelerated filer
|
|
☐
|
|
|
|
|
Non-accelerated filer
|
|
☐ (Do not check if a smaller reporting company)
|
|
Smaller reporting company
|
|
☐
|
|
|
|
|
|
|
|
|
Emerging growth company
|
|
☐
|
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period
for complying with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act. ☐